Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 207 | 326 | 261 | 341 | 212 |
| Cost of Goods | 115 | 121 | 118 | 151 | 120 |
| Gross Profit | 93 | 204 | 143 | 190 | 91 |
| Operating Expenses | 1,508 | 1,087 | 1,532 | 1,436 | 1,804 |
| Operating Income | -1,415 | -883 | -1,389 | -1,247 | -1,713 |
| Interest Expense | 8 | 9 | 9 | 3 | 1 |
| Other Income | 14 | 8 | -7 | 4 | 12 |
| Pre-tax Income | -1,409 | -883 | -1,405 | -1,246 | -1,701 |
| Net Income Continuous | -1,409 | -883 | -1,405 | -1,246 | -1,701 |
| Net Income | $-1,409 | $-883 | $-1,405 | $-1,246 | $-1,701 |
| EPS Basic Total Ops | -0.01 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | 0.00 | -0.01 | -0.01 | -0.01 |
| EBITDA(a) | $-1,330 | $-795 | $-1,312 | $-1,156 | $-1,638 |